Skip to main content
Premium Trial:

Request an Annual Quote

Regulus IDs miRNA Target in GSK Collaboration

Premium

Regulus Therapeutics said this week that it has identified a third, undisclosed microRNA target under its ongoing collaboration with GlaxoSmithKline.

The discovery triggers a preclinical milestone payment of an undisclosed amount, Regulus said.

The companies began working together in 2008, and expanded their alliance in 2010 (GSN 2/25/2010).

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.